Capital Advantage’s Veoneer, Inc. VNE Stock Holding History

Capital Advantage’s Portfolio VNE Stock Details VNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,377	Closed	-$205K	–	116
2021 Q1	$205K	Buy	+8,377	New	+$219K	0.06%	106
2018 Q4	–	Sell	-8,377	Closed	-$461K	–	82
2018 Q3	$461K	Buy	+8,377	New	+$431K	0.11%	46

Other funds holding VNE

CCI

Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $18.3B AUM 23.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Advantage's VNE Position: Q2 2021 in Review

Capital Advantage sold out of Veoneer, Inc. (VNE) in Q2 2021, closing a stake of 8,377 shares — an estimated $205K sold.

Capital Advantage first reported a position in VNE in Q3 2018 and held it in 2 quarters. The position peaked at $461K in Q3 2018. 99 funds tracked by Wall St. Rank hold VNE as of Q2 2021.

Capital Advantage reported no remaining Veoneer, Inc. position as of Q2 2021 after selling out during the quarter.
Capital Advantage sold 8,377 Veoneer, Inc. shares in Q2 2021, an estimated $205K.
Capital Advantage first reported a position in Veoneer, Inc. in Q3 2018 and held it in 2 quarters.
Capital Advantage's Veoneer, Inc. position peaked at $461K in Q3 2018.
99 funds tracked by Wall St. Rank held Veoneer, Inc. as of Q2 2021.

Based on Capital Advantage's 13F filing for Q2 2021, filed 16 Aug 2021.